Source: Annual Congress 2005 - Progresses in lung fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Guillemot, T. Billette, A. Clement, M. T. Vanier, E. Ralph, C. Troadec (Paris, Lyon, France). Bronchoalveolar lavage fluid analysis is essential for early diagnosis of respiratory manifestation in Niemann-Pick disease. Eur Respir J 2005; 26: Suppl. 49, 1323

Member's Comments

No comment yet.

Related content which might interest you: The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis Source: Eur Respir J 2003; 21: 407-413 Year: 2003 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease Source: Eur Respir Rev 2010 19: 237-241 Year: 2010 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Clinical and immunological parameters in patients with newly diagnosed sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Airway dendritic cell phenotypes in inflammatory diseases of the human lung Source: Eur Respir J 2007; 30: 878-886 Year: 2007 The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases Source: Eur Respir Mon; 2009: 46: 36–46 Year: 2009 Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP) Source: Eur Respir J 2004; 24: Suppl. 48, 46s Year: 2004 Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases Source: International Congress 2016 – Connective tissue disorders Year: 2016 The relationship between the course of sarcoidosis and changes of markers of the disease activity in a bronchoalveolar lavage fluid Source: Eur Respir J 2002; 20: Suppl. 38, 469s Year: 2002 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Analysis of functional, radiologic, and bronchoalveolar lavage findings in patients with diffuse parenchymal lung diseases Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Galactomannans in bronchoalveolar lavage of patients with Idiopathic Pulmonary Fibrosis (IPF): a possible marker of disease progression. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Cytofluorimetric BAL cells characterization in IPF and in other ILD Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Source: International Congress 2015 – New insights into IIPs Year: 2015 Bronchoalveolar lavage: did it fulfill its promises? Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice Year: 2005